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Abstract 51 
Dietary fatty acids play a role in glucose homeostasis. The aim of this study was to assess the 52 
individual relationship between dietary saturated (SFA), monounsaturated (MUFA) and 53 
polyunsaturated (PUFA) fatty acids with postprandial β-cell function and insulin sensitivity 54 
in subjects with normal and high fasting triglycerides. We assessed postprandial β-cell 55 
function (by the insulinogenic index and the ratio of the insulin to glucose areas under the 56 
time-concentration curve) and insulin sensitivity (by the oral glucose and the minimal model 57 
insulin sensitivity indices) over four nonconsecutive, randomly assigned, high-fat meals 58 
containing a panel of SFA (palmitic and stearic acids), MUFA (palmitoleic and oleic acids) 59 
and PUFA (linoleic and α-linolenic acids) in 14 subjects with normal and 14 subjects with 60 
high fasting triglycerides. The proportions of each fatty acid in the meals and the values for 61 
surrogate measures of postprandial β-cell function and insulin sensitivity were subjected to a 62 
Pearson correlation and hierarchical cluster analysis, which revealed two classes of dietary 63 
fatty acids in regulating postprandial glucose homeostasis. We successfully discriminated the 64 
adverse specific effects of SFA palmitic acid but the beneficial specific effects of MUFA 65 
oleic acid on postprandial β-cell function (r ≥ 0.84 for SFA palmitic acid and r ≥ -0.71 for 66 
MUFA oleic acid; P<0.05) and insulin sensitivity (r ≥ -0.92 for SFA palmitic acid and r ≥ 67 
0.89 for MUFA oleic acid; P<0.001) both in subjects with normal and high fasting 68 
triglycerides. In conclusion, dietary MUFA oleic acid, in contrast to SFA palmitic acid, 69 
favours the tuning towards a better postprandial glycaemic control in subjects with normal 70 
and high fasting triglycerides. 71 
 72 
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Introduction 76 
Dietary substitution of saturated fatty acids (SFA) with monounsaturated ones (MUFA) 77 
improves glucose homeostasis and influences protection against cardiovascular risk factors 78 
and the metabolic syndrome
1
. In vitro and in animal models, palmitic acid (16:0) is 79 
considered the main culprit of SFA impairing pancreatic β-cell function and insulin 80 
sensitivity, whereas the major dietary MUFA oleic acid (18:1n-9) is protective for β-cells and 81 
insulin target tissues
2,3
. 82 
 83 
In previous studies, we have shown that consumption of meals rich in dietary fats with a high 84 
MUFA-to-SFA ratio may decrease exacerbated insulin excursion and increase insulin 85 
sensitivity in the postprandial period in subjects with normal fasting triglycerides
4
. Similar 86 
findings were observed in subjects with high fasting triglycerides when meals enriched in 87 
SFA and MUFA were compared
5
. However, information regarding the individual 88 
contribution of each dietary SFA and MUFA to postprandial glucose homeostasis in humans 89 
is yet unknown. Therefore, we extended the panel of different dietary fats with a gradual 90 
change in the MUFA-to-SFA ratio in subjects with high fasting triglycerides and reanalysed 91 
the previously collected data to investigate whether the content of palmitic acid or stearic 92 
acid (18:0), among the major dietary SFA in the meals, or the content of oleic acid or 93 
palmitoleic acid (16:1n-7), among the major dietary MUFA in the meals, displays linear 94 
relationship with surrogate measures of insulin secretion and action in the postprandial period 95 
in subjects with normal and high fasting triglycerides. We also extended this reanalysis to the 96 
polyunsaturated fatty acids (PUFA), linoleic acid (18:2n-6) and α-linolenic acid (18:3n-3). 97 
 98 
Results 99 
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All of the high-fat meals elicited a comparable postprandial glucose but different insulin and 100 
NEFA responses either in subjects with normal (Figure 1, left panels) or high (Figure 1, 101 
right panels) fasting triglycerides. The incremental AUC for triglycerides (from 0 to 480 min) 102 
in subjects with normal fasting triglycerides were as follows: 5.27 ± 0.54, 3.75 ± 0.73, 4.45 ± 103 
0.53 and 4.79 ± 0.36 mmol/h × L after the ingestion of the butter, HPSO, ROO and VEFO 104 
meals, respectively (all P < 0.05, except the values after the ROO and VEFO meals that did 105 
not statistically differ). The incremental AUC for triglycerides (from 0 to 480 min) in 106 
subjects with high fasting triglycerides were as follows: 13.43 ± 2.73, 4.30 ± 1.21, 6.48 ± 107 
2.20 and 7.07 ± 1.27 mmol/h × L after the ingestion of the butter, HPSO, ROO and VEFO 108 
meals, respectively (all P < 0.05, except the values after the ROO and VEFO meals that did 109 
not statistically differ). The suppression of NEFA concentrations in the early postprandial 110 
period was mediated by hyperinsulinemia but this association was dependent on the type of 111 
dietary fat in the meals [r = 0.987 (95% CI: 0.959, 0.995) in subjects with normal fasting 112 
triglycerides (Figure 1, left panel at the bottom) and r = 0.983 (95% CI: 0.946, 0.994) in 113 
subjects with high fasting triglycerides; all P < 0.01] (Figure 1, right panel at the bottom). 114 
 115 
A Pearson correlation analysis and hierarchical cluster analysis were performed to determine 116 
the detailed relationship between the individual fatty acids in the meals and the surrogate 117 
measures of postprandial β-cell function and insulin sensitivity. These analytical results 118 
showed two major dietary fatty acid clusters. The SFA palmitic and stearic acids, and the 119 
MUFA palmitoleic acid were included in one cluster, which was characterized by a positive 120 
response on postprandial β-cell function but a negative response on postprandial insulin 121 
sensitivity both in subjects with normal (Figures 2 and 3A) and high (Figures 3B and 4) 122 
fasting triglycerides. Importantly, only the SFA palmitic acid was positively correlated 123 
(P<0.01) with all of the surrogate measures of postprandial β-cell function [r = 0.94 for the 124 
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insulinogenic index (IGI) and 0.91 for the ratio of the insulin to glucose areas under the time-125 
concentration curve (AUCINS/AUCGLU) in subjects with normal fasting triglycerides and r = 126 
0.91 for IGI and 0.84 for AUCINS/AUCGLU in subjects with high fasting triglycerides] and 127 
negatively correlated (P<0.001) with all of the surrogate measures of postprandial insulin 128 
sensitivity [r = -0.92 for the oral glucose insulin sensitivity index from 0 to 180 min (OGIS0-129 
180) and -0.94 for the minimal model insulin sensitivity index from 0 to 480 min (IS0-480) in 130 
subjects with normal fasting triglycerides and r = -0.97 for OGIS0-480 and -0.92 for IS0-480 in 131 
subjects with high fasting triglycerides]. The other cluster contained the MUFA oleic acid 132 
and the PUFA linoleic and α-linolenic acids that participated in a negative response on 133 
postprandial β-cell function but a positive response on postprandial insulin sensitivity both in 134 
subjects with normal (Figures 2 and 3A) and high (Figures 3B and 4) fasting triglycerides. 135 
However, only the MUFA oleic acid was negatively correlated (P<0.05) with all of the 136 
surrogate measures of postprandial β-cell function (r = -0.71 for IGI and -0.97 for 137 
AUCINS/AUCGLU in subjects with normal fasting triglycerides and r = -0.89 for IGI and -0.99 138 
for AUCINS/AUCGLU in subjects with high fasting triglycerides) and positively correlated 139 
(P<0.05) with all of the surrogate measures of postprandial insulin sensitivity (r = 0.89 for 140 
IGI and 0.93 for AUCINS/AUCGLU in subjects with normal fasting triglycerides and r = 0.91 141 
for IGI and 0.96 for AUCINS/AUCGLU in subjects with high fasting triglycerides). 142 
 143 
Discussion 144 
In 1959, Kinsell and co-workers
6
 suggested that dietary fatty acids might have a role in 145 
glucose homeostasis. Several decades later, evidence is accumulating from in vitro and 146 
animal studies that chain-length and double bonds in fatty acids influence its insulinotropic, 147 
pro- or anti-lipotoxic and insulin-sensitizing potencies
7-9
. In humans, long-term high-MUFA 148 
as compared to high-SFA diets appears to be effective for fasting glycaemic control in 149 
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healthy subjects and patients with obesity, type 2 diabetes and the metabolic syndrome
1,10
. 150 
Consistent with this notion, we have demonstrated that subjects with normal
4
 and high
5
 151 
fasting triglycerides became less insulin resistant postprandially as the proportion of MUFA 152 
vs. SFA in dietary fats increased, which led to a dramatic attenuation of the functional 153 
demand on the β-cell. Here we extend this knowledge and provide evidence of specific 154 
associations of dietary MUFA oleic acid, in opposite direction to dietary SFA palmitic acid, 155 
with postprandial β-cell function and insulin sensitivity. Our study also indicates that dietary 156 
SFA stearic, MUFA palmitoleic and PUFA linoleic or α-linolenic acids remain neutral 157 
regarding the antagonism of dietary MUFA oleic and SFA palmitic acids on postprandial 158 
glycaemic control. 159 
 160 
In this study, each participant served as his own control. The only difference among meals 161 
was the type of dietary fat, which provided different fatty acids at different proportions. In the 162 
postprandial period, fats absorbed in the small intestine are assembled by enterocytes to 163 
produce the triglyceride-rich lipoprotein chylomicron, whose fatty acid composition closely 164 
resembles that of fatty acid composition in the meals
11
. Next, circulating chylomicrons may 165 
gain access to target tissues, including pancreas, liver, adipose tissue and skeletal muscle that 166 
express lipoprotein lipase, fatty-acid–activated G-protein coupled receptors and fatty acid-167 
translocase FAT/CD36
12-14
. It should be noted that the molar concentration of circulating 168 
fatty acids in chylomicrons is ~30-fold larger than fatty acids bound to albumin. In agreement 169 
with Shah et al.
15
 we found postprandial hyperinsulinemia combined with suppressed 170 
circulating NEFA after the ingestion of the high-fat meals, suggesting that not the systemic 171 
NEFA pool but the abrupt local increase of fatty acids from hydrolysed chylomicrons in the 172 
immediate vicinity of the β-cells, hepatocytes, adipocytes and skeletal muscle cells is likely 173 
critical for glycaemic control in the fed state. This conclusion can also be inferred from tight 174 
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associations between the content of MUFA oleic and SFA palmitic acids in the meals and the 175 
change in surrogate measures of postprandial β-cell function and insulin sensitivity. Our 176 
study further shows that the achievement of postprandial glycaemic control may be fine-177 
tuned by adjusting the type and proportion of these fatty acids in the diet, irrespective of the 178 
fasting triglyceride concentration. 179 
 180 
Although it remains difficult to estimate the relative importance of meals rich in MUFA oleic 181 
acid or SFA palmitic acid to the evolution of pancreatic compensation, it seems clear that in 182 
pancreatic islets, whereas short-term MUFA and SFA promotes (palmitic acid > oleic acid) 183 
the rate of β-cell production
16
, only long-term SFA palmitic acid accelerates the impairment 184 
of the same production rate
17
. Mathematical models of long-term diabetes progression predict 185 
that continued and exacerbated fluctuations of β-cell function exert a fall of β-cell mass and 186 
replication that prevents compensation, so that a picture of frank diabetes eventually 187 
develops
18
. In addition, acute episodes of postprandial hyperinsulinemia, despite insulin-188 
mediated suppression of circulating NEFA, recently have been linked to cardiac steatosis in 189 
healthy subjects
19
. Therefore, our results raise the interesting possibility that input of dietary 190 
MUFA oleic acid alleviates the needs for glucose disposal during non-fasting periods with 191 
minor impact on β-cells and insulin target tissues. This scenario may offer an important 192 
additional view to the adipose tissue output of fatty acids with lipokine activity in fasting 193 
states
20,21
. 194 
 195 
Experimental 196 
Design and recruitment 197 
The design and some of the results on postprandial studies in these subjects with normal and 198 
high fasting triglycerides were published
4,5
. Here the panel of different dietary fats with a 199 
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gradual change in the MUFA-to-SFA ratio has been completed in subjects with high fasting 200 
triglycerides and all of the data were reanalysed to achieve the aim of the study. Briefly, these 201 
were randomized, double-blind, within-subject crossover 4-d feeding studies. All 202 
experiments were performed in compliance with the relevant laws and institutional guidelines 203 
and the Human Clinical Commission and the Ethics Committee at University Hospital Virgen 204 
del Rocio (Seville, Spain) approved protocols before the start of the study, and written 205 
consent was obtained from each participant. Caucasian, nonsmoking males were recruited: 206 
healthy subjects (BMI: 23.9 ± 1.9 kg/m
2
) and newly diagnosed with type IIb or IV 207 
hyperlipoproteinemia (fasting triglycerides >2.24 mmol/L) according to the National 208 
Cholesterol Education Program Adult Treatment Panel III (BMI: 24.2 ± 5.1 kg/m
2
)
22
. 209 
 210 
Four separate visits at intervals of 1-2 wk were designed to compare responses to high-fat 211 
meals containing different fatty acids at different proportions (Table 1). Subjects presented at 212 
0800 h after a 12 h fast. Baseline values for triglycerides (0.86 ± 0.27 and 4.22 ± 0.72 213 
mmol/L), nonesterified fatty acids (NEFA) (465 ± 87 and 500 ± 73 µmol/L), glucose (5.16 ± 214 
0.38 and 5.77 ± 0.64 mmol/L), insulin (49 ± 9 and 90 ± 10 pmol/L), homeostatic model 215 
assessment (HOMA) for β-cell function (HOMA-B: 28 ± 4 and 48 ± 6 pmol/mmol) and for 216 
insulin resistance (HOMA-IR: 11.2 ± 1.1 and 22.9 ± 2.4 pmol × mmol/L
2
) were obtained in 217 
subjects with normal and high fasting triglycerides. Subjects were provided with a 218 
standardized high-fat meal that consisted of a dietary fat [50 g/m
2
 body surface area of butter, 219 
high-palmitic sunflower oil (HPSO), refined olive oil (ROO) or a mixture of vegetable and 220 
fish oils (VEFO)], along with a portion of plain pasta (30 g/m
2
 body surface area), one slice 221 
of brown bread and one skimmed yogurt. Following the ingestion of the meals, blood 222 
samples were collected each 60 min in appropriate tubes for determination of NEFA, glucose 223 
and insulin levels over 480 min. 224 
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 225 
Calculations 226 
A sample size of 14 subjects per group was calculated to provide 80% power, assuming a 227 
comparable effect on the postprandial excursion of plasma insulin levels and considering a 228 
two-sided test with a significance level of 5%. Postprandial β-cell function was estimated by 229 
two methods: 1) the insulinogenic index (IGI), which is a surrogate measure of first-phase 230 
insulin secretion and was calculated using the difference between the postprandial insulin 231 
peak (t = 60 min) and the fasting insulin level in relation to the difference in glucose levels 232 
(IGI = ∆I0-60/∆G0-60); and 2) the ratio of the insulin to glucose areas under the time-233 
concentration curve (AUCINS/AUCGLU), which significantly correlates with glucose 234 
sensitivity and early-phase insulin secretion, calculated using the trapezoidal method from 0 235 
to 120 min. Postprandial insulin sensitivity was estimated by two methods: 1) the oral 236 
glucose insulin sensitivity index from 0 to 180 min (OGIS0-180); and 2) the minimal model 237 
insulin sensitivity index from 0 to 480 min (IS0-480). The details of the equations and 238 
references using this multisampling protocol have been previously described
4
. 239 
 240 
Laboratory methods 241 
Plasma glucose and triglycerides were measured on a Hitachi Modular Analytics D-2400 242 
analyser (Roche Diagnostics, Basel, Switzerland) using commercially available reagents and 243 
enzyme-based kit. Plasma insulin was measured using a specific enzyme-linked 244 
immunosorbant assay (Dako, Cambridge, UK) on a Hitachi Modular Analytics E-170 245 
analyser. Plasma NEFA were measured using an ACS-ACOD assay (Wako Chemicals 246 
GmbH, Germany) on a COBAS Mira-Plus analyser. Fatty acid composition in the meals was 247 
determined as described
23
. 248 
 249 
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Statistical analyses 250 
Comparisons of quantitative variables were performed using ANOVA, and a Bonferroni 251 
correction was applied for the post hoc detection of significant pairwise differences. A 252 
Pearson correlation was used to explore the strength of the association between the content of 253 
each fatty acid in the meals with postprandial estimates of β-cell function and insulin 254 
sensitivity. Thereafter, a hierarchical cluster analysis applying average linkage method of 255 
Euclidean distances and a heatmap visualization of the correlation coefficients were 256 
performed. Statistical significance was set at P values < 0.05. Data were analysed using 257 
StatView and MeV for Windows. 258 
 259 
Conclusion 260 
We provide evidence demonstrating the individual contribution of major dietary SFA, MUFA 261 
and PUFA to postprandial β-cell function and insulin sensitivity both in subjects with normal 262 
and high fasting triglycerides. This study shows that postprandial glycaemic control may be 263 
at risk by dietary SFA palmitic acid but not SFA stearic acid and may be protected by dietary 264 
MUFA oleic acid but not MUFA palmitoleic acid. The clinical significance of our findings 265 
may benefit nutrition management for prevention of acute insulin disorders by customized 266 
ranges of dietary fatty acids. 267 
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Table 1. Composition of principal fatty acids that are common in the meals
a
. 348 
 Butter HPSO ROO VEFO 
Fatty acid g/100 g fatty acids 
16:0 31.8 24.9 11.7 5.4 
16:1n-7 2.4 6.8 1.0 0.6 
18:0 13.3 2.0 2.8 4.2 
18:1n-9 26.2 58.7 79.8 74.4 
18:2n-6 3.0 6.9 3. 6 10.3 
18:3n-3 0.4 0.04 0.5 0.3 
     
SFA 65.3 27.2 14.9 10.7 
MUFA 31.3 65.8 81.1 75.4 
PUFA 3.4 7.0 4.0 13.9 
 349 
a 
The butter meal had also short or medium chain SFA [butyric acid (4:0) 2.0, caproic acid 350 
(6:0) 1.4, caprylic acid (8:0) 0.9, capric acid (10:0) 2.0, lauric acid (12:0) 2.5, myristic acid 351 
(14:0) 9.9, pentadecanoic acid (15:0) 0.8, margaric acid (17:0) 0.6] and MUFA [myristoleic 352 
acid (14:1n-7) 0.5, pentadecenoic acid (15:1n-7) 1.1, eicosenoic acid (20:1n-9) 0.6]. Other 353 
fatty acids [17:0 < 0.1, heptadecenoic acid (17:1n-7) < 0.1, arachidic acid (20:0) < 0.4, 20:1n-354 
9 < 0.3] were detected in the HPSO, ROO, and VEFO meals. The VEFO meal had 355 
eicosapentaenoic acid (20:5n-3) 1.0 and docosahexaenoic acid (22:6n-3) 2.3. All values are in 356 
g/100 g fatty acids. 357 
 358 
 359 
 360 
 361 
 362 
 363 
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FIGURE LEGENDS 364 
Fig. 1. Time-course of plasma concentrations (after subtracting baseline values) and 365 
incremental AUC (iAUC) (inserts) of glucose, insulin and NEFA during the postprandial 366 
period from 0 to 480 min, and correlations between iAUC of insulin and NEFA during the 367 
early postprandial period (from 0 to 180 min) (top) in response to the meals (butter: red, 368 
HPSO: orange, ROO: green, VEFO: blue) in subjects with normal (left panels) and high 369 
(right panels) fasting triglycerides. Units for iAUC of glucose, insulin and NEFA: mmol/h × 370 
L, pmol/h × L and µmol/h × L, respectively. Labeled means in a column without a common 371 
letter differ, P<0.05. All values are mean ± SD (n = 14). 372 
 373 
Fig. 2. Pearson correlation analysis between the proportions of principal fatty acids in the 374 
meals and the values for surrogate measures of postprandial β-cell function and insulin 375 
sensitivity in subjects with normal fasting triglycerides. Data are strength (r) and significance 376 
(P) of correlation derived from Pearson’s correlation analysis. 377 
 378 
Fig. 3. Hierarchical cluster analysis and heatmap of the results obtained from the effects of 379 
principal fatty acids in the meals on surrogate measures of insulin secretion and action in the 380 
postprandial period in subjects with normal (A) and high (B) fasting triglycerides. Each 381 
square indicates the Pearson correlation coefficient of a pair of fatty acid vs. surrogate 382 
measure, and the value for the correlation coefficient is represented by the intensity of the red 383 
or green colour, as indicated on the colour scale. Hierarchical clusters are represented by a 384 
cluster tree. 385 
 386 
Fig. 4. Pearson correlation analysis between the proportions of principal fatty acids in the 387 
meals and the values for surrogate measures of postprandial β-cell function and insulin 388 
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sensitivity in subjects with high fasting triglycerides. Data are strength (r) and significance 389 
(P) of correlation derived from Pearson’s correlation analysis. 390 
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